Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06439290
Other study ID # ONZ-2024-0049/ONZ-2024-0081
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 10, 2024
Est. completion date December 2027

Study information

Verified date May 2024
Source University Ghent
Contact Evelien D'haeseleer, PhD
Phone +32 9 332 24 67
Email evelien.dhaeseleer@ugent.be
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to measure the short- and long-term voice outcome and outcome predictors of glottoplasty, cricothyroid approximation, thyroplasty, and chondrolaryngoplasty using a prospective non-randomized controlled trial and a multidimensional voice assessment protocol. Secondly, a laryngeal magnetic resonance imaging protocol will be developed to measure pre- and postoperative anatomical factors and compare them with the acoustic changes.


Description:

Gender-affirming voice surgery (such as glottoplasty, cricothyroid approximation, thyroplasty and chondrolaryngoplasty), in addition to gender-affirming voice training and hormone therapy, plays an important role in achieving a gender-congruent voice in transgender and gender diverse people. In addition, these interventions are sometimes performed on cisgender men or women who wish to change their voice. However, the impact of these interventions on broad voice characteristics needs to be further investigated. A thyroid chondroplasty is a procedure in which the cartilage of the larynx is flattened to make the larynx ("Adam's apple") less visible. This procedure is sometimes performed in combination with voice surgery. Although clinically in some cases we observe a temporary lowering of the pitch of the voice during thyroid chondroplasty, little is known in the literature about the impact of this surgery on voice characteristics. The first purpose is to measure the effect of glottoplasty, cricothyroid approximation, thyroplasty and/or thyroid chondroplasty on a) acoustic voice characteristics (such as the pitch and resonance of the voice), b) perception of femininity/masculinity, c) psychosocial well-being and satisfaction and d) the function of the vocal folds. Persons undergoing a glottoplasty, cricothyroid approximation, thyroplasty and/or thyroid chondroplasty in the head and neck surgery department are routinely invited to several pre- and postoperative check-up appointments in the head and neck surgery and ear, nose and throat department. These people will be invited to participate in the study in which the data, which are routinely collected preoperatively, 1 week, 1 month, 6 months and 12 months postoperatively during a speech-language pathology (SLP) consultation and a head and neck surgery consultation. These data will be used for scientific research to study the outcome of such surgery on phonation. These pre- and post-operative consultations are clinically standard. During these consultations, a voice assessment and videolaryngostroboscopic examination of the vocal folds are routinely performed. Recordings and images obtained through these studies can be further processed in the context of this scientific research (such as conducting a listening experiment, analyzing (e.g. using the VALI form) and measuring the video laryngostroboscopy results, etc.). Secondly, factors (determinants) that influence the effect of previous surgical interventions will be studied within this research. The third purpose of this study is to develop and validate a laryngeal magnetic resonance imaging (MRI) protocol using a laryngeal surface coil to measure pre- and postoperative anatomical factors (vocal fold length and thickness, thyroarytenoid muscle mass and area) and compare them with the acoustic changes.


Recruitment information / eligibility

Status Recruiting
Enrollment 290
Est. completion date December 2027
Est. primary completion date December 2027
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility PURPOSE 1: Inclusion criteria for surgery participants: - Persons who will soon undergo surgery on the vocal folds and/or larynx (including glottoplasty, cricothyroid approximation, thyroplasty and/or thyroid chondroplasty) at UZ Gent - At least 18 years old - Sufficient command of the Dutch language for understanding the informed consent letter and completing Dutch questionnaires Inclusion criteria for volunteers to provide speech samples: - Cisgender men or women Inclusion criteria for volunteer listeners for the listening experiment: - Dutch-speaking - Self-reported normal hearing PURPOSE 2: same as above. PURPOSE 3: Inclusion criteria for the healthy participants: - At least 18 years old - Sufficient command of the Dutch language to complete a Dutch questionnaire Exclusion criteria for the healthy participants: - One or more contraindications for an MRI examination. These contraindications are checked using a questionnaire (safety checklist). Inclusion criteria for the pre- and postoperative MRI participants: - Random selection of +- 10 participants of purpose 1. Exclusion criteria for the pre- and postoperative MRI participants: - One or more contraindications for an MRI examination. These contraindications are checked using a questionnaire (safety checklist).

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Phonosurgery
Gender-affirming voice surgery (such as glottoplasty, cricothyroid approximation, thyroplasty and chondrolaryngoplasty), in addition to gender-affirming voice training and hormone therapy, plays an important role in achieving a gender-congruent voice in transgender and gender diverse people. In addition, these interventions are sometimes performed on cisgender men or women who wish to change their voice. However, the impact of these interventions on broad voice characteristics needs to be further investigated.
Mastectomy/breast augmentation
Control group of PFAB and PMAB persons undergoing a mastectomy or breast augmentation surgery.

Locations

Country Name City State
Belgium Ghent University Ghent East-Flanders
Belgium Ghent University Hospital Ghent East-Flanders

Sponsors (1)

Lead Sponsor Collaborator
University Ghent

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Speaking fo Speaking fundamental frequency pre, post 1 (1 week), post 2 (1 month), post 3 (6 months), post 4 (1 year)
Primary FF 1-5 Formant frequencies 1-5 pre, post 1 (1 week), post 2 (1 month), post 3 (6 months), post 4 (1 year)
Primary Perceptual femininity/masculinity score Self-perception and listener perceptions of femininity and masculinity. Visual analogue scale (0 = very masculine, 100 = very feminine). pre, post 1 (1 week), post 2 (1 month), post 3 (6 months), post 4 (1 year)
Secondary Vocal capacity Dysphonia Severity Index, cut-off score 1.6 (above 1.6 is normophonic) pre, post 1 (1 week), post 2 (1 month), post 3 (6 months), post 4 (1 year)
Secondary Vocal range Voice Range Profile (min-max of fo and intensity (SPL)) pre, post 1 (1 week), post 2 (1 month), post 3 (6 months), post 4 (1 year)
Secondary Vocal quality Acoustic Voice Quality Index, cut-off score 2.95 (below 2.95 is normophonic) pre, post 1 (1 week), post 2 (1 month), post 3 (6 months), post 4 (1 year)
Secondary Laryngeal function Flexible videolaryngostroboscopy pre, post 1 (1 week), post 2 (1 month), post 3 (6 months), post 4 (1 year)
Secondary PROMs: Voice Handicap Index Voice Handicap Index, score from 0-120, the higher the score, the worse. pre, post 1 (1 week), post 2 (1 month), post 3 (6 months), post 4 (1 year)
Secondary PROMs: Trans Woman Voice Questionnaire Trans Woman Voice Questionnaire, score from 1-120, the higher the score, the worse. pre, post 1 (1 week), post 2 (1 month), post 3 (6 months), post 4 (1 year)
Secondary Other PROMs Visual analogue scales to measure satisfaction (VAS with 0=strongly disagree, 100=strongly agree). pre, post 1 (1 week), post 2 (1 month), post 3 (6 months), post 4 (1 year)
See also
  Status Clinical Trial Phase
Recruiting NCT05583916 - Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery N/A
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT03213314 - HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies N/A
Enrolling by invitation NCT05534490 - Surgery and Functionality in Older Adults N/A
Recruiting NCT04792983 - Cognition and the Immunology of Postoperative Outcomes
Terminated NCT04612491 - Pre-operative Consultation on Patient Anxiety and First-time Mohs Micrographic Surgery
Recruiting NCT06397287 - PROM Project Urology
Recruiting NCT04444544 - Quality of Life and High-Risk Abdominal Cancer Surgery
Completed NCT04204785 - Noise in the OR at Induction: Patient and Anesthesiologists Perceptions N/A
Completed NCT03432429 - Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study
Completed NCT04176822 - Designing Animated Movie for Preoperative Period N/A
Recruiting NCT05370404 - Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain: N/A
Not yet recruiting NCT05467319 - Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS Phase 3
Recruiting NCT04602429 - Children's Acute Surgical Abdomen Programme
Completed NCT03124901 - Accuracy of Noninvasive Pulse Oximeter Measurement of Hemoglobin for Rainbow DCI Sensor N/A
Completed NCT04595695 - The Effect of Clear Masks in Improving Patient Relationships N/A
Recruiting NCT06103136 - Maestro 1.0 Post-Market Registry
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04059328 - Novel Surgical Checklists for Gynecologic Laparoscopy in Haiti
Recruiting NCT03697278 - Monitoring Postoperative Patient-controlled Analgesia (PCA) N/A